(3R,4R,5S)-4-acetamido-5-amino-N-((1-(naphthalen-2-ylmethyl)-1H-1,2,3-triazol-4-yl)methyl)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxamide

ID: ALA4455147

Chembl Id: CHEMBL4455147

PubChem CID: 155524680

Max Phase: Preclinical

Molecular Formula: C28H36N6O3

Molecular Weight: 504.64

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)NCc2cn(Cc3ccc4ccccc4c3)nn2)C[C@H](N)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C28H36N6O3/c1-4-24(5-2)37-26-14-22(13-25(29)27(26)31-18(3)35)28(36)30-15-23-17-34(33-32-23)16-19-10-11-20-8-6-7-9-21(20)12-19/h6-12,14,17,24-27H,4-5,13,15-16,29H2,1-3H3,(H,30,36)(H,31,35)/t25-,26+,27+/m0/s1

Standard InChI Key:  ZDMFXOVLXSQBHK-OYUWMTPXSA-N

Alternative Forms

  1. Parent:

    ALA4455147

    ---

Associated Targets(non-human)

NA Neuraminidase (1107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.64Molecular Weight (Monoisotopic): 504.2849AlogP: 2.83#Rotatable Bonds: 10
Polar Surface Area: 124.16Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.60CX Basic pKa: 9.11CX LogP: 2.41CX LogD: 0.71
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.39Np Likeness Score: -0.50

References

1. Ju H, Xiu S, Ding X, Shang M, Jia R, Huang B, Zhan P, Liu X..  (2020)  Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.,  187  [PMID:31835169] [10.1016/j.ejmech.2019.111940]

Source